Latest News in the pharma Industry

Research & Development

CiMaas and PharmaCell Enter a Collaborative Agreement

CiMaas and PharmaCell Enter a Collaborative Agreement

13 Jul 2015

Read more 
In a Pivotal Study, Genentech’s Investigational Immunotherapy Atezolizumab Shrank Tumours in People With a Specific Type of Bladder Cancer

In a Pivotal Study, Genentech’s Investigational Immunotherapy Atezolizumab Shrank Tumours in People With a Specific Type of Bladder Cancer

13 Jul 2015

Read more 
Cevec’s CAPGo Derived Recombinant Placental Human Alkaline Phosphatase Shows Superior Results in a Preclinical Study

Cevec’s CAPGo Derived Recombinant Placental Human Alkaline Phosphatase Shows Superior Results in a Preclinical Study

10 Jul 2015

Read more 
Regeneron and Sanofi Announce Phase III Results Showing LDL-C Reductions of More Than 60% in Japanese Patients Treated with Praluent Injection

Regeneron and Sanofi Announce Phase III Results Showing LDL-C Reductions of More Than 60% in Japanese Patients Treated with Praluent Injection

10 Jul 2015

Read more 
Esperion Therapeutics Announces Removal of 240 mg Partial Clinical Hold for ETC-1002

Esperion Therapeutics Announces Removal of 240 mg Partial Clinical Hold for ETC-1002

8 Jul 2015

Read more 
Glycotope Biotechnology and Cantargia Sign Production Agreement for Lead Product Candidate CAN04

Glycotope Biotechnology and Cantargia Sign Production Agreement for Lead Product Candidate CAN04

6 Jul 2015

Read more 
Biogen and AGTC Enter Collaboration to Develop Gene Therapies in Ophthalmology

Biogen and AGTC Enter Collaboration to Develop Gene Therapies in Ophthalmology

3 Jul 2015

Read more 
Bavarian Nordic Announces Option Exercise by US Government for Development of Filovirus Vaccine

Bavarian Nordic Announces Option Exercise by US Government for Development of Filovirus Vaccine

30 Jun 2015

Read more 
Genentech’s Ocrelizumab Significantly Reduced Both Relapses and Disability Progression Versus Interferon Beta-1a in Two Phase III Studies

Genentech’s Ocrelizumab Significantly Reduced Both Relapses and Disability Progression Versus Interferon Beta-1a in Two Phase III Studies

30 Jun 2015

Read more 
Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma

Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma

29 Jun 2015

Read more 
Amarna Therapeutics Teaming Up with Austrian CBmed in the Development of Immunotherapies

Amarna Therapeutics Teaming Up with Austrian CBmed in the Development of Immunotherapies

29 Jun 2015

Read more 
Cyramza (Ramucirumab) Hepatocellular Carcinoma Data Published by The Lancet Oncology

Cyramza (Ramucirumab) Hepatocellular Carcinoma Data Published by The Lancet Oncology

23 Jun 2015

Read more